Children's Memorial Hospital is one of eight Medical Centers participating in this two year, double blind, placebo controlled study which is a phase four clinical trial of the IgE blocker Xolair. In this segment join host, Dr. Bill Rutenberg learn from co-investigator, Dr. Jacqueline Pongracic about the logistics of conducting the study.
Children's Memorial Hospital is one of eight Medical Centers participating in this two year, double blind, placebo controlled study which is a phase four clinical trial of the IgE blocker Xolair. In this segment join host, Dr. Bill Rutenberg learn from co-investigator, Dr. Jacqueline Pongracic about the logistics of conducting the study.
